Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.273 | 51 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.4115 | 56 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.25375 | 52 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.22515 | 52 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.1962 | 51 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.29085 | 50 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.26306 | 50 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.29398 | 53 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.52767 | 59 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.23516 | 52 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.24135 | 52 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.22806 | 52 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.22915 | 51 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.24385 | 52 |